Pathophysiological effects of glucocorticoids on nasal polyps: An update

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 1, 2005, Pages 31-35

  Benson, Mikael ^a  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Glucocorticoids; Microarray; Nasal polyps

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UTEROGLOBIN;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ASTHMA; DNA MICROARRAY; DRUG EFFECT; EOSINOPHIL; GENE; HUMAN; LEUKOCYTE COUNT; MAST CELL; NOSE POLYP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 12944327881     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200502000-00007     Document Type: Review

References (29)

1. Mygind N, Dahl R, Bachert C. Nasal polyposis, eosinophil dominated inflammation and allergy. Thorax 2000; 55(Suppl 2):S79-S83.
2. Pawankar R. Nasal polyposis: an update. Curr Opin Allergy Clin Immunol 2003; 3:1-6. An excellent and comprehensive review of the various pathogenic mechanisms whereby nasal polyposis may occur.
3. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107:607-614.
4. Hamilos DL, Thawley SE, Kramper MA, et al. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol 1999; 103:79-87.
5. Pelaia G, Vatrella A, Cuda G, et al. Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci 2003; 72:1549-1561. An excellent review of the effects of glucocorticoids on airway diseases.
6. Benson M, Strannegard I-L, Strannegard O, Wennergren G. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils. J Allergy Clin Immunol 2000; 106:307-312.
7. Benson M, Olsson M, Rudemo M, et al. Pros and cons of microarray technology in allergy research. Clin Exp Allergy 2004; 34:1001-1006.
8. Webster JC, Huber RM, Hanson RL, et al. Dexamothasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types. Endocrinology 2002; 143:3866-3874.
9. Yoshida NL, Miyashita TUM, Yamada M, et al. Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem Biophys Res Commun 2002; 17:293:1254-1261.
10. Maurer M, Trajanoski Z, Frey G, et al. Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. Horm Metab Res 2001; 33:691-695.
11. Obexer P, Certa U, Kofler R, Helmberg A. Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis. Oncogene 2001; 19:4324-4336.
12. Tonko M, Ausserlechner MJ, Bernhard D, et al. Gene expression profiles of proliferating vs. G1/G0 arrested human leukaemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J 2001; 15:693-699.
13. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156:4422-4428.
14. Leung DY, Hamid Q, Vottero A, et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med 1997; 186:1567-1574.
15. Hamilos DL, Leung DY, Muro S, et al. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 2001; 100:59-68.
16. Knutsson PU, Bronnegard M, Marcus C, et al. Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide. J Allergy Clin Immunol 1996; 97:655-661.
17. Pujols L, Mullol J, Benitez P, et al. Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells. Respir Med 2003; 97:90-96. This article shows an association between leukocyte infiltration in nasal polyps and the balance between the two isoforms of the human glucocorticoid receptor.
18. Papon JF, Coste A, Gendron MC, et al. HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps. Laryngoscope 2002; 112:2067-2075.
19. Mastruzzo C, Greco LR, Nakano K, et al. Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation. J Allergy Clin Immunol 2003; 112:37-44. This article indicates that the beneficial effects of glucocorticoids may depend on upregulation of antiinflammatory genes, that is TGF-β.
20. Sime PJ, Xing Z, Graham FL, et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100:768-776.
21. Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150:17-22.
22. Hirano S, Asano K, Namba M, et al. Induction of apoptosis in nasal polyp fibroblasts by glucocorticoids in vitro. Acta Otolaryngol 2003; 123:1075-1079.
23. Watanabe K, Shirasaki H, Kanaizumi E, Himi T. Effects of glucocorticoids on infiltrating cells and epithelial cells of nasal polyps. Ann Otol Rhinol Laryngol 2004; 113:465-473.
24. Benson M, Carlsson L, Adner M, et al. Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps. J Allergy Clin Immunol 2004; 113:1137-1143.
25. Levy D, Clish CB, Schmidt B, et al. Lipid mediator class switching during acute inflammation; signals in resolution. Nat Immunol 2001; 2:612-619.
26. Berg T, Cassel TN, Schwarze PE, Nord M. Glucocorticoids regulate the CCSP and CYP2B1 promoters via C/EBPbeta and delta in lung cells. Biochem Biophys Res Commun 2002; 293:907-912.
27. Sohn J, Kim TI, Yoon YH, et al. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest 2003; 111:121-128.
28. Fritz SB, Terrell JE, Conner ER, et al. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol 2003; 112:1057-1063.
29. Laing IA, Hermans C, Bernard A, et al. Association between plasma CC16 levels, the A38G polymorphism, and asthma. Am J Respir Crit Care Med 2000; 161:124-127.